Loading insider details...
Latest Form 4 (Aug 20, 2026): Sale of 400 ACRV shares, $804.00.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Aug 20, 2026 | Acrivon Therapeutics, Inc. (ACRV) | Sale | 400 | $804.00 |
| May 20, 2026 | Acrivon Therapeutics, Inc. (ACRV) | Grant/Award | 38,584 | n/a |
| May 18, 2026 | Acrivon Therapeutics, Inc. (ACRV) | Tax Withholding | 404 | $775.68 |
| Mar 3, 2026 | Acrivon Therapeutics, Inc. (ACRV) | Grant/Award | 94,946 | n/a |
| Feb 18, 2026 | Acrivon Therapeutics, Inc. (ACRV) | Tax Withholding | 471 | $767.73 |
| Nov 18, 2025 | Acrivon Therapeutics, Inc. (ACRV) | Tax Withholding | 403 | $902.72 |
| Aug 18, 2025 | Acrivon Therapeutics, Inc. (ACRV) | Tax Withholding | 403 | $560.17 |
| May 16, 2025 | Acrivon Therapeutics, Inc. (ACRV) | Tax Withholding | 403 | $459.42 |
| Mar 4, 2025 | Acrivon Therapeutics, Inc. (ACRV) | Grant/Award | 78,078 | n/a |
| Feb 19, 2025 | Acrivon Therapeutics, Inc. (ACRV) | Tax Withholding | 469 | $2.5K |